Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones11-14

DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ shed 1.07% to $11.07 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 2.29% to 22,870.36 and Dow Jones Industrial Average falling 1.65% to 47,457.22.

Corbus Pharmaceuticals Holdings Inc. closed 46.16% short of its 52-week high of $20.56, which the company reached on October 20th.

Despite its losses, the stock outperformed some of its competitors Thursday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 1.59% to $4.34, Fortress Biotech Inc. (FBIO) fell 4.96% to $2.49, and Viking Therapeutics Inc. (VKTX) fell 4.36% to $39.00.

Trading volume (275,856) remained 104,531 below its 50-day average volume of 380,387.

Data source: Dow Jones Market Data, FactSet. Data compiled November 13, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

November 13, 2025 17:23 ET (22:23 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2583510772?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-14 06:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583510772","market":"us","top_or_hot":-1,"title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Corbus Pharmaceuticals Holdings Inc. <a href=\"https://laohu8.com/S/CRBP\">$(CRBP)$</a> shed 1.07% to $11.07 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.29% to 22,870.36 and Dow Jones Industrial Average  falling 1.65% to 47,457.22. \n</p>\n<p>\n     Corbus Pharmaceuticals Holdings Inc. closed 46.16% short of its 52-week high of $20.56, which the company reached on October 20th. \n</p>\n<p>\n     Despite its losses, the stock outperformed some of its competitors Thursday, as Vanda Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/VNDA\">$(VNDA)$</a> fell 1.59% to $4.34, <a href=\"https://laohu8.com/S/FBIO\">Fortress Biotech Inc.</a> (FBIO) fell 4.96% to $2.49, and <a href=\"https://laohu8.com/S/VKTX\">Viking</a> <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc. (VKTX) fell 4.36% to $39.00. \n</p>\n<p>\n     Trading volume (275,856) remained 104,531 below its 50-day average volume of 380,387. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled November 13, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 13, 2025 17:23 ET (22:23 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCorbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-11-14 06:23</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Corbus Pharmaceuticals Holdings Inc. <a href=\"https://laohu8.com/S/CRBP\">$(CRBP)$</a> shed 1.07% to $11.07 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.29% to 22,870.36 and Dow Jones Industrial Average  falling 1.65% to 47,457.22. \n</p>\n<p>\n     Corbus Pharmaceuticals Holdings Inc. closed 46.16% short of its 52-week high of $20.56, which the company reached on October 20th. \n</p>\n<p>\n     Despite its losses, the stock outperformed some of its competitors Thursday, as Vanda Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/VNDA\">$(VNDA)$</a> fell 1.59% to $4.34, <a href=\"https://laohu8.com/S/FBIO\">Fortress Biotech Inc.</a> (FBIO) fell 4.96% to $2.49, and <a href=\"https://laohu8.com/S/VKTX\">Viking</a> <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc. (VKTX) fell 4.36% to $39.00. \n</p>\n<p>\n     Trading volume (275,856) remained 104,531 below its 50-day average volume of 380,387. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled November 13, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 13, 2025 17:23 ET (22:23 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRBP","symbol_name":"Corbus Pharmaceuticals Holdings, Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2583510772","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2583510772","pubTimestamp":1763072580,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  shed 1.07% to $11.07 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.29% to 22,870.36 and Dow Jones Industrial Average  falling 1.65% to 47,457.22.Corbus Pharmaceuticals Holdings Inc. closed 46.16% short of its 52-week high of $20.56, which the company reached on October 20th.Despite its losses, the stock outperformed some of its competitors Thursday, as Vanda Pharmaceuticals Inc.  fell 1.59% to $4.34, Fortress Biotech Inc.  fell 4.96% to $2.49, and Viking Therapeutics Inc.  fell 4.36% to $39.00.Trading volume  remained 104,531 below its 50-day average volume of 380,387.Data source: Dow Jones Market Data, FactSet. Data compiled November 13, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently ","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"CRBP":"Corbus Pharmaceuticals Holdings, Inc."},"translate_title":"尽管当天下跌，Corbus Pharmaceuticals Holdings Inc.股票的表现仍优于竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRBP":1.5},"content_text":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ shed 1.07% to $11.07 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.29% to 22,870.36 and Dow Jones Industrial Average  falling 1.65% to 47,457.22. \n\n\n     Corbus Pharmaceuticals Holdings Inc. closed 46.16% short of its 52-week high of $20.56, which the company reached on October 20th. \n\n\n     Despite its losses, the stock outperformed some of its competitors Thursday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 1.59% to $4.34, Fortress Biotech Inc. (FBIO) fell 4.96% to $2.49, and Viking Therapeutics Inc. (VKTX) fell 4.36% to $39.00. \n\n\n     Trading volume (275,856) remained 104,531 below its 50-day average volume of 380,387. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled November 13, 2025. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 13, 2025 17:23 ET (22:23 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2583510772","isCrawlerRequest":true}